Vacunas最新文献

{"title":"Interactions between human microbiota and vaccines; Current perspectives","authors":"Masoud Keikha , Mehdi Zandhaghighi , Shahram Shahraki Zahedani","doi":"10.1016/j.vacun.2022.12.006","DOIUrl":"10.1016/j.vacun.2022.12.006","url":null,"abstract":"","PeriodicalId":53407,"journal":{"name":"Vacunas","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41582855","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Factores asociados a la intención de vacunación contra el COVID-19 en Popayán, Cauca, Colombia","authors":"Omar Andrés Ramos Valencia ,&nbsp;Yuliana Buitrón Gonzalez ,&nbsp;Jorge Sotelo Sotelo Daza ,&nbsp;Andrés Felipe Villaquiran","doi":"10.1016/j.vacun.2023.01.003","DOIUrl":"https://doi.org/10.1016/j.vacun.2023.01.003","url":null,"abstract":"<div><p>Vaccination against the COVID-19 pandemic, decreed by the WHO in 2020, has shown in the initial trials an admissible efficacy for the scientific community, but with many doubts and concerns for the communities, developing the phenomenon known as vaccine hesitancy.</p></div><div><h3>Objective</h3><p>To understand the factors associated with the intention or rejection of vaccination against COVID-19 in the city of Popayán in the year 2022.</p></div><div><h3>Methodology</h3><p>Cross-sectional descriptive-analytical study, carried out between August 2021 and March 2022; with a non-probabilistic sampling, for convenience, with a sample size of 993 people; A questionnaire-type survey was applied in person and virtually to know the intention of vaccination, knowledge and perceptions.</p></div><div><h3>Results</h3><p>The surveyed population was characterized as 56.19% female, 49.24% between 18 and 28 years old; 23.16% state that they do not intend to be vaccinated against COVID-19, the main reasons being: not being well informed 56.29%, ineffective vaccine 54.8% and that the vaccine weakens the immune system 27,5%; as well as the low confidence with the Vaccination Plan and with the pharmaceutical companies that produce the vaccine.</p></div><div><h3>Conclusion</h3><p>The intention to vaccinate against COVID-19 is determined not only by the technical-administrative dynamics of the immunization program and the health system, variables of the context and the perception of risk, add up to explain the vaccination processes.</p></div>","PeriodicalId":53407,"journal":{"name":"Vacunas","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49728686","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Incidence of sudden sensorineural hearing loss associated with BNT162b2 COVID-19 vaccine: Pooled results from register-based nationwide studies","authors":"Paulo Ricardo Martins-Filho","doi":"10.1016/j.vacun.2023.01.004","DOIUrl":"10.1016/j.vacun.2023.01.004","url":null,"abstract":"","PeriodicalId":53407,"journal":{"name":"Vacunas","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9874040/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9333507","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"El fin de la emergencia internacional de salud pública por COVID-19: ¿y ahora qué?","authors":"Núria Torner","doi":"10.1016/j.vacun.2023.05.002","DOIUrl":"https://doi.org/10.1016/j.vacun.2023.05.002","url":null,"abstract":"","PeriodicalId":53407,"journal":{"name":"Vacunas","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49728746","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Prevalence and risk factors of adverse effects after the first COVID-19 booster dose: evidence from Greece","authors":"Petros Galanis ,&nbsp;Aglaia Katsiroumpa ,&nbsp;Irene Vraka ,&nbsp;Vanessa Chrysagi ,&nbsp;Olga Siskou ,&nbsp;Olympia Konstantakopoulou ,&nbsp;Theodoros Katsoulas ,&nbsp;Parisis Gallos ,&nbsp;Daphne Kaitelidou","doi":"10.1016/j.vacun.2023.05.005","DOIUrl":"10.1016/j.vacun.2023.05.005","url":null,"abstract":"<div><h3>Background</h3><p>In general, COVID-19 vaccines are safe and effective, but minor adverse effects are common. However, adverse effects have not been measured in several countries including Greece.</p></div><div><h3>Objective</h3><p>To estimate the prevalence of adverse effects after the first COVID-19 booster dose, and to identify possible risk factors.</p></div><div><h3>Material and methods</h3><p>We conducted a cross-sectional study with a convenience sample in Greece during November 2022. We measured several adverse effects after the booster dose, such as fatigue, headaches, fever, chills, nausea, etc. We considered gender, age, chronic disease, self-assessment of health status, COVID-19 diagnóstico, and self-assessment of COVID-19 course as possible predictors of adverse effects.</p></div><div><h3>Results</h3><p>In our sample, 96% developed at least one adverse effect. Half of the participants (50.2%) developed one to five adverse effects, 35.9% developed six to ten adverse effects, and 9.5% developed 11 to 16 adverse effects. Mean number of adverse effects was 5.5. The most frequent adverse effects were pain at the injection site (84.3%), fatigue (70.8%), muscle pain (61%), swelling at the injection site (55.2%), headache (49.8%), fever (42.9%), and chills (41%). Females developed more adverse effects than males (p &lt; 0.001). The prevalence of adverse effects of COVID-19 vaccines was statistically significant and positively associated with the severity of COVID-19 among COVID-recovered individuals (p &lt; 0.05). Moreover, younger age was associated with increased adverse effects (p &lt; 0.001).</p></div><div><h3>Conclusions</h3><p>Almost all participants in our study developed minor adverse effects after the booster dose. Female gender, COVID-19 patients with worse clinical course, and younger individuals experienced more often adverse effects.</p></div>","PeriodicalId":53407,"journal":{"name":"Vacunas","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10213299/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9720367","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Vaccination coverage among laboratory personnel - health safety imperative for all","authors":"Sabina Šegalo ,&nbsp;Arzija Pašalić ,&nbsp;Daniel Maestro ,&nbsp;Zhaohui Su ,&nbsp;Nafija Serdarević ,&nbsp;Anes Jogunčić ,&nbsp;Aida Ramić-Čatak ,&nbsp;Almedina Hajrović ,&nbsp;Snežana Unčanin ,&nbsp;Lejla Čano Dedić ,&nbsp;Berina Hasanefendić","doi":"10.1016/j.vacun.2022.12.003","DOIUrl":"10.1016/j.vacun.2022.12.003","url":null,"abstract":"<div><h3>Aim</h3><p><span>The objective of the study was to evaluate disparities in </span>vaccination coverage<span> among laboratory personnel in health care facilities and to identify risk factors for nonvaccination.</span></p></div><div><h3>Materials and methods</h3><p>A multicenter, quantitative, cross-sectional study was conducted between November 2020 and February 2021. The validated bilingual questionnaire was distributed online through professional association networks. Descriptive and inferential statistics were included in the analysis.</p></div><div><h3>Results</h3><p><span><span>Of the 640 respondents, approximately one-third (30.9%) had received an annual influenza vaccination. Significantly higher vaccination coverage rates were reported for </span>measles, tuberculosis, and hepatitis B (82.8%, 78.3%, and 72.5%, respectively). Influenza vaccination coverage was higher among LPs with higher education (</span><em>p</em><span> &lt; 0.001), in microbiology laboratories (</span><em>p</em> = 0.009), in the private sector (<em>p</em> = 0.012), and twice as high in EU countries (<em>p</em> &lt; 0.001). Measles vaccination coverage was lower among LPs older than 45 years (<em>p</em> &lt; 0.001), had a college degree (<em>p</em> = 0.015), and were EU citizens (<em>p</em> = 0.002). Better tuberculosis vaccination coverage was found among LPs older than 45 years (<em>p</em> &lt; 0.001), with higher educational degrees (<em>p</em> = 0.003), employed in microbiology laboratories (<em>p</em> = 0.004), and working in the private sector (<em>p</em> = 0.025). Hepatitis B vaccination coverage was higher among LPs under 45 years (<em>p</em> = 0.020), with higher levels of education (<em>p</em> = 0.003), and with respect to territorial affiliation (<em>p</em> &lt; 0.001).</p></div><div><h3>Conclusion</h3><p>The present study showed that the vaccination coverage rate was satisfactory for most LPs against hepatitis B, tuberculosis, and measles, while the coverage rate against influenza was low.</p></div>","PeriodicalId":53407,"journal":{"name":"Vacunas","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47983313","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Vacunación frente a la COVID-19 a partir de los 6 meses de edad. Completando el círculo de la prevención en pediatría","authors":"Fernando Moraga-Llop","doi":"10.1016/j.vacun.2022.12.004","DOIUrl":"https://doi.org/10.1016/j.vacun.2022.12.004","url":null,"abstract":"","PeriodicalId":53407,"journal":{"name":"Vacunas","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49730487","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Azucena Saavedra Pérez","authors":"","doi":"10.1016/S1576-9887(23)00026-2","DOIUrl":"https://doi.org/10.1016/S1576-9887(23)00026-2","url":null,"abstract":"","PeriodicalId":53407,"journal":{"name":"Vacunas","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49756815","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Differences in elderly stress levels before Covid-19 vaccination: History of exposure to Covid-19 reduces stress before vaccination","authors":"Kristian Budi Setiawan ,&nbsp;Isna Hikmawati ,&nbsp;Dita Pratiwi Kusuma Wardani ,&nbsp;Juanita Juanita","doi":"10.1016/j.vacun.2022.10.005","DOIUrl":"10.1016/j.vacun.2022.10.005","url":null,"abstract":"<div><h3>Background</h3><p>The Covid-19 pandemic requires the government to take various prevention and countermeasures, one of which is the Covid-19 Vaccination program, however, the program experiences a high dropout at various doses and causes <em>immunization stress related response</em> (ISRR), especially in the elderly. The research aims to determine differences in the stress levels of the elderly before the covid-19 vaccination.</p></div><div><h3>Methods</h3><p>Descriptive study with the elderly population who will take vaccinations at the Bojong Purbalingga Health Center. Sampling used random sampling, the inclusion criteria were 45–79 years old, with a total sample of 90 respondents. Research instruments developed by research, relating to vaccination containing cognitive responses (such as difficulty concentrating), physiological responses (such as shortness of breath, dry lips) feelings of fear, anxiety, trust in vaccination. Data were analyzed descriptively with percentages and proportions.</p></div><div><h3>Results</h3><p>The results showed that the most moderate stress levels were middle age (22.2%), women 33.3% had higher stress levels than men (10%), the highest vaccination coverage was 26.7% at a distance of 1–2 KM. The level of stress is in the moderate category 33.3% in the elderly who have never been exposed to Covid-19 and 10% in the elderly who have been exposed. Non-family health workers, 36.7% higher than families of health workers (6.7%).</p></div><div><h3>Conclusion</h3><p>Stress levels before vaccination are higher in the elderly who have never been exposed to Covid-19, compared to those who have been exposed to Covid-19. The need for family assistance to prepare for vaccination in the elderly.</p></div>","PeriodicalId":53407,"journal":{"name":"Vacunas","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9622388/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9279414","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Knowledge and awareness of Algerian healthcare workers about human monkeypox and their attitude toward its vaccination: An online cross-sectional survey","authors":"Mohamed Lounis ,&nbsp;Djihad Bencherit ,&nbsp;Samir Abdelhadi","doi":"10.1016/j.vacun.2022.11.003","DOIUrl":"10.1016/j.vacun.2022.11.003","url":null,"abstract":"<div><h3>Objectives</h3><p>This study was carried out to assess the level of knowledge of Algerian healthcare workers about human monkeypox, and their attitude toward its vaccination.</p></div><div><h3>Methods</h3><p>An online-based cross-sectional study using social media platforms targeting Algerian healthcare workers was conducted between 28 June and 18 September 2022.</p></div><div><h3>Results</h3><p>111 healthcare workers have answered the questionnaire. Overall, a medium level of knowledge (64.9%) was obtained with multiple gaps about the epidemiology and clinical features of this disease. Factors associated with high levels of knowledge included young age, being married and practicing outside the province town. Also, only 38.7% of the respondents were in favor of human monkeypox vaccination if recommended for free with COVID-19 vaccine uptake as a determinant factor of acceptance.</p></div><div><h3>Conclusion</h3><p>Results have shown a medium level of knowledge and a low rate of vaccination willingness. The findings of this study although not representative of all Algerian healthcare workers, could be a baseline for human monkeypox knowledge and vaccination in Algeria.</p></div>","PeriodicalId":53407,"journal":{"name":"Vacunas","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9946789/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9288693","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}